NovoCure Ltd (NVCR)
28.90
-0.11
(-0.38%)
USD |
NASDAQ |
Jan 08, 16:00
28.90
0.00 (0.00%)
After-Hours: 17:23
NovoCure Cash from Financing (Quarterly): 0.10M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
Abbott Laboratories | -1.576B |
LeMaitre Vascular Inc | -3.148M |
Insulet Corp | 7.80M |
Globus Medical Inc | 19.58M |
Perspective Therapeutics Inc | 0.628M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 10.38M |
Cash from Investing (Quarterly) | 10.19M |
Free Cash Flow | -78.21M |
Free Cash Flow Per Share (Quarterly) | -0.0028 |
Free Cash Flow to Equity (Quarterly) | -1.319M |
Free Cash Flow to Firm (Quarterly) | -0.307M |
Free Cash Flow Yield | -2.52% |